- A new study suggests some of the genetic risk linked to type 1 diabetes is active not only in immune and pancreatic cells, but also in brain cells.
- The findings may help explain why some people with type 1 diabetes experience brain fog, slower thinking or memory problems.
- This does not prove type 1 diabetes directly causes cognitive problems, but it suggests both may share some underlying biology.
Type 1 diabetes is usually described as an autoimmune disease in which the immune system attacks insulin-producing cells in the pancreas.
That is true, but a new study suggests the story may be broader than that.
Researchers found that genetic variants linked to type 1 diabetes risk are also active in certain brain cells.
The most important signal appeared in microglia, which are the brain’s resident immune cells.
That matters because some people with type 1 diabetes report cognitive symptoms such as brain fog, slower processing or memory lapses.
These problems are often blamed on blood sugar swings alone.
This study suggests there may be something deeper going on.
The researchers used large population datasets, including the UK Biobank, to compare around 20,000 people with type 1 diabetes with roughly 500,000 without it.
They then mapped the relevant genetic signals across different brain cell types.
The overlap with microglia stood out.
The researchers also used Mendelian randomisation to explore whether genetic liability linked to cognitive traits was associated with type 1 diabetes risk.
They found evidence of shared pathways, although not a simple cause-and-effect relationship.
- Type 1 diabetes: Hybrid closed-loop and open-loop systems compared
- Screening all children for type 1 diabetes is effective
- Plant-based eating may help some people with type 1 diabetes use less insulin
That is the key point.
This is not proof that type 1 diabetes causes cognitive difficulties, or that brain changes drive diabetes directly.
It is evidence that both may be influenced by some of the same biological architecture.
That shifts the way type 1 diabetes is framed.
Instead of thinking about it only as a pancreas-and-immune-system disease, this work points towards a more systemic view that includes neuroimmune interactions too.
That does not change day-to-day treatment yet.
But it may eventually help explain why some people with type 1 diabetes struggle cognitively even when glucose is not the whole story.
